AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: ALUNBRIG (Takeda Pharmaceutical Company) (alunbrig.com)
This is a high-substance clinical site that uses patient storytelling as a bridge to complex trial data. It contains the minimum amount of fluff allowed by modern pharmaceutical marketing standards. The score is only elevated from ‘Minimal’ to ‘Low’ due to the technical absence of direct outbound links to peer-reviewed sources in the crawled text snippets and the use of testimonials for efficacy signaling.
Integrate direct outbound links to the New England Journal of Medicine or Lancet Oncology publications for the ALTA trial data. Add a clear disclaimer beneath patient testimonial videos stating that ‘individual results may vary’ to separate anecdotal hope from statistical clinical probability. Include a ClinicalTrials.gov ID (NCT number) directly in the sub-page headings for maximum transparency. Replace the ‘Review Count’ schema with ‘Patient Story’ markers to avoid the appearance of trust theatre.
Information density is exceptionally high for a public-facing website. The body text is saturated with specific clinical metrics such as the 74% tumor shrinkage rate vs 62% for crizotinib and a median progression-free survival of 24 months. Headings are functional rather than promotional, though there is necessary repetition of the drug’s indication for regulatory compliance. Power words are almost entirely absent, replaced by technical nouns like kinase inhibitor and brain metastases.
If your primary content isn't server side, your site collapses into an empty shell for every LLM. Check your server side content exposure and confirm whether AI can extract anything meaningful at all.
There is virtually zero semantic drift between the homepage and sub-pages. The homepage establishes the drug’s primary signal for ALK+ mNSCLC, and sub-pages (efficacy and resistance) deliver deep-dive data supporting both first-line and second-line treatment paths. The internal logic remains consistent: a once-daily pill backed by Blinded Independent Review Committee results.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site triggers trust theatre flags because it lists review_count (1 to 6) without external proof_links in the metadata, a common byproduct of pharma websites hosting patient testimonials. While the clinical claims are substantiated by study names like ALTA 1L, the use of individual patient videos (Eric, Greg, Katie) to frame efficacy results like ‘complete metabolic response’ creates a minor credibility gap where anecdotal evidence is used to soften hard clinical data. The trust_theatre_flag is true on all 4 pages, accounting for the majority of points in this pillar.
Proof density is very high, with specific patient counts (275 total in the ALTA 1L study), age ranges (27 to 89), and objective metrics (N.E.D. status) provided. The ratio of verifiable evidence to vague assertions is roughly 8:1, with the only vague points being found in the emotive sections of patient testimonials.
For a demonstration of entity driven retail architecture, open the Walmart Structured Data audit. View the Walmart Structured Data Audit to see how product, brand, and service entities are reconstructed for AI systems.
The site follows a rigid pharmaceutical template (ISI, Patient Stories, Dosing, Resources) which is industry-standard rather than generic BS. Cliché usage is low, though terms like ‘where science meets compassion’ and ‘hope’ are utilized in patient transcripts. The value proposition is entirely unique as it refers to a specific, patented chemical compound, making it impossible to ‘copy-paste’ onto a competitor without violating FDA and patent laws.
Authority is well-established through robust MedicalWebPage schema that correctly identifies the drug’s non-proprietary name (brigatinib) and specialty (oncologic). The ‘named experts’ are patients rather than physicians, but their roles are clearly defined as personal experiences rather than clinical endorsements. Technical implementation is clean with a valid heading hierarchy and sophisticated structured data.
There is no disconnect between marketing tone and substance. When the site claims the drug ‘helped shrink tumors in the brain,’ it immediately follows with specific sample sizes (41 patients) and percentage responses (78% vs 26%). This level of forensic granularity is the antithesis of bullshit.
Medical Devices, Pharma & Biotech BS: ALUNBRIG (Takeda Pharmaceutical Company) (alunbrig.com)
The site perfectly aligns with the Pharma & Biotech industry, specifically the oncology sub-sector. The content is heavily regulated, focusing on a specific FDA-approved molecular entity (brigatinib) with mandatory safety disclosures and clinical trial data.
AI retrieval begins with one question: "What is this page?" Read the Structured Data Technical Guide to learn how correct entity typing and persistent identifiers prevent your site from collapsing into noise.
“The score of 18 is driven primarily by the trust_and_proof pillar (8 points) due to the presence of unverified testimonial counts in the schema and anecdotal efficacy claims. Information density and authority gaps are nearly zero, reflecting the highly technical and regulated nature of the product. The site is a benchmark for low-BS communication in the pharma sector.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 29, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at ALUNBRIG (Takeda Pharmaceutical Company) to view the most current version of their content and see directly what the company offers.